BioRestorative Therapies
Price & Volume
Stats
See more52W Range | $1.03-$2.55 |
Market Cap | $12.1M |
Shares Short | 329,694 |
Financials
See moreRevenue (12 Mos) | $401,000 |
Revenue Growth (YoY) | 124.4% |
Gross Profit (12 Mos) | $372,928 |
Diluted EPS | -$1.16 |
News
See moreYahoo Finance • 3 days ago
BioRestorative to Participate in Benzinga All-Access Show Today to Discuss Recent Achievements of Key Clinical & Regulatory Milestones, and Highlight Commercial Opportunities
Yahoo Finance • 8 days ago
BioRestorative Confirms No Material Impact from Reciprocal Tariffs; All BRTX-100 Production & Manufacturing Performed in the United States
Yahoo Finance • 29 days ago
BioRestorative Therapies to Report 2024 Financial Results and Host Conference Call on March 27, 2025
Yahoo Finance • 2 months ago
BioRestorative Announces FDA Clearance of IND for Phase 2 Trial of BRTX-100 in Chronic Cervical Discogenic Pain
About
CEO | Mr. Lance Alstodt |
Address | 40 Marcus Drive, Melville, NY, United States, 11747 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 11 |
